← Companies|Itamar Medical (Zoll)
It

Itamar Medical (Zoll)

Caesarea ILFounded 2001200 employees
Private CapbiotechAcquiredCardiology
Platform: WatchPAT Sleep
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
ZorirasimodITA-6103Phase 1/21Gene TherapyB7-H3PRMT5iFabry
ITA-9145ITA-9145NDA/BLA2DegraderPI3KαBiTEAngelman
DoxabrutinibITA-7373Phase 2/32RadioligandFcRnBCMA ADCADHD
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (6)
2025-10-07
Zorirasimod Ph2 Data
Fabry
Past
2025-10-14
ITA-9145 Ph1 Dose Esc
Angelman
Past
2026-03-03
ITA-9145 Ph3 Readout
Angelman
Past
2030-02-24
ITA-9145 Ph3 Readout
Angelman
Ph3 Readout
2030-10-17
Doxabrutinib Ph3 Readout
ADHD
Ph3 Readout
2031-02-04
Doxabrutinib Ph3 Readout
ADHD
Ph3 Readout